Public health advisory issued over discovery of new benzodiazepine in drug seizure
Source ↗
👁 0
💬 0
The NWT’s chief public health officer (CPHO) has issued a public health advisory over the discovery of ethylflualprazolam, a new benzodiazepine, in illicit drugs seized by the Yellowknife RCMP in late July.
The substance — a whitish, grainy powder — is a high-potency benzodiazepine, first detected in Canada on Dec. 16, 2025. The drug is related to alprazolam, known by its brand name Xanax, and has not been approved for medical use. Ethylflualprazolam is often sold as counterfe
The substance — a whitish, grainy powder — is a high-potency benzodiazepine, first detected in Canada on Dec. 16, 2025. The drug is related to alprazolam, known by its brand name Xanax, and has not been approved for medical use. Ethylflualprazolam is often sold as counterfe
Comments (0)